Darmstadt, Germany

Claudia Wilm


 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Muhltal, DE (1997 - 2000)
  • Mühltal, DE (2001)
  • Darmstadt, DE (1998 - 2020)

Company Filing History:


Years Active: 1997-2020

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Claudia Wilm - Innovator in Antibody Development

Introduction

Claudia Wilm is a prominent inventor based in Darmstadt, Germany, known for her significant contributions to the field of antibody development. With a total of 12 patents to her name, she has made remarkable strides in the medical and biotechnological sectors. Her work focuses on creating innovative solutions for diagnostic applications, particularly in cancer research.

Latest Patents

Among her latest patents is the "Diagnostic anti-PD-L1 antibody and use thereof." This invention provides an antibody or antigen-binding fragment that binds to an epitope within human PD-L1 with high specificity and reproducibility. The antibody can be utilized in assessing PD-L1 expression in tissue samples, aiding in patient stratification. Another notable patent is "Antibodies for the detection of integrin complexes in FFPE material." This invention relates to antibodies capable of binding the extracellular domain of integrin, with applications in detecting integrins in archival formalin-fixed paraffin-embedded (FFPE) tissue. The patent also includes methods for preparing monoclonal rabbit antibodies and screening anti-integrin antibodies that are particularly suited for immunohistochemistry in FFPE material.

Career Highlights

Claudia has worked with notable companies such as Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent GmbH. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in antibody technology.

Collaborations

Throughout her career, Claudia has collaborated with esteemed colleagues, including Werner Mederski and Mathias Osswald. These partnerships have fostered an environment of innovation and have led to the successful development of her patented technologies.

Conclusion

Claudia Wilm's contributions to the field of antibody development are invaluable. Her innovative patents and collaborations highlight her dedication to advancing medical diagnostics. Her work continues to impact the scientific community and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…